Browsing Centre for Clinical Pharmacology by Subject "action potentials"

Now showing items 1-1 of 1

    • Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1). 

      Ang, R; Mastitskaya, S; Hosford, PS; Basalay, M; Specterman, M; Aziz, Q; Li, Y; Orini, M; Taggart, P; Lambiase, PD (2018-10)
      BACKGROUND: Glucagon-like peptide-1 receptor (GLP-1R) agonists improve cardiovascular outcomes in patients with type 2 diabetes mellitus. However, systemic actions of these agents cause sympathetic activation, which is ...